×


 x 

Shopping cart
8%OFFRoger Mcintyre - Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities - 9781107074583 - V9781107074583
Stock image for illustration purposes only - book cover, edition or condition may vary.

Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities

€ 114.36
€ 104.66
You save € 9.70!
FREE Delivery in Ireland
Description for Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities hardcover. The first book to comprehensively assemble research, clinical, and public policy perspectives on cognitive dysfunction in major depressive disorder. Editor(s): McIntyre, Roger S.; Cha, Danielle S. Num Pages: 336 pages, 26 b/w illus. 7 colour illus. 19 tables. BIC Classification: MMH. Category: (P) Professional & Vocational. Dimension: 234 x 156. .
Major depressive disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principal determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research ... Read more

Product Details

Publisher
Cambridge University Press
Format
Hardback
Publication date
2016
Condition
New
Weight
781g
Number of Pages
370
Place of Publication
Cambridge, United Kingdom
ISBN
9781107074583
SKU
V9781107074583
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-12

About Roger Mcintyre
Roger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada. Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Reviews for Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities

Goodreads reviews for Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities


Subscribe to our newsletter

News on special offers, signed editions & more!